comparemela.com
Home
Live Updates
Galapagos Stock: Strong On Jyseleca Positive Clinical Data (GLPG) : comparemela.com
Galapagos Stock: Strong On Jyseleca Positive Clinical Data (GLPG)
Galapagos' flagship product, Jyselec, is used to treat rheumatoid arthritis and ulcerative colitis. Click here to read more about what makes GLPG stock a Buy.
Related Keywords
Japan
,
China
,
France
,
Romainville
,
France General
,
Galapago Jyseleca
,
European Medicines Agency
,
Contract Research Organization
,
Launches Phase
,
European Medicines
,
Galapago Phase
,
Strasbourg Based Contract Research Organization
,
comparemela.com © 2020. All Rights Reserved.